CYP19A1 and Obesity: This condition can be summarized as a greater share of circulating estrogens (in addition to those possibly increased by the presence of obesity and by the greater aromatase activity) resulting from the action of the gut microbiota and is an inherent risk factor for all hormone-dependent oncological diseases such as mammary and endometrial cancer.